| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.201.629 | 11.692.099 | 8.263.497 | 11.081.344 | 12.594.042 | 8.240.884 | 3.270.427 |
| Total Income - EUR | - | - | - | 4.109.494 | 12.171.656 | 9.368.124 | 11.902.614 | 13.714.613 | 10.473.790 | 3.477.317 |
| Total Expenses - EUR | - | - | - | 4.063.076 | 11.199.236 | 9.993.000 | 12.106.128 | 13.438.290 | 15.132.786 | 3.473.414 |
| Gross Profit/Loss - EUR | - | - | - | 46.418 | 972.420 | -624.875 | -203.514 | 276.323 | -4.658.995 | 3.904 |
| Net Profit/Loss - EUR | - | - | - | 39.088 | 824.140 | -624.875 | -203.514 | 276.323 | -4.658.995 | 3.904 |
| Employees | - | - | - | 108 | 121 | 134 | 127 | 117 | 52 | 40 |
Check the financial reports for the company - Marchand Pharma Tech S.a.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 170.474 | 1.197.654 | 1.786.056 | 1.761.938 | 2.535.974 | 2.123.308 | 1.196.288 |
| Current Assets | - | - | - | 4.480.537 | 3.831.220 | 4.753.479 | 4.435.501 | 5.753.052 | 1.906.819 | 3.430.020 |
| Inventories | - | - | - | 1.168.257 | 158.092 | 3.716.280 | 1.421.510 | 2.576.667 | 817.173 | 839.472 |
| Receivables | - | - | - | 3.230.140 | 3.577.159 | 1.019.139 | 2.582.286 | 2.692.239 | 1.080.886 | 2.587.571 |
| Cash | - | - | - | 82.141 | 95.970 | 18.060 | 431.705 | 484.145 | 8.759 | 2.977 |
| Shareholders Funds | - | - | - | 1.532.609 | 2.327.069 | 1.660.318 | 1.420.435 | 1.701.165 | -2.962.988 | -2.791.689 |
| Social Capital | - | - | - | 1.493.521 | 1.464.597 | 1.436.832 | 1.404.969 | 1.409.328 | 1.405.054 | 1.397.202 |
| Debts | - | - | - | 2.050.163 | 2.701.805 | 4.879.216 | 4.777.004 | 6.598.799 | 6.996.412 | 7.420.162 |
| Income in Advance | - | - | - | 1.068.239 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1011 - 1011" | |||||||||
| CAEN Financial Year |
1011
|
|||||||||
Comments - Marchand Pharma Tech S.a.